Zebularine has been shown to be selective towards cancer cells, but is eventually less effective in early stage or less aggressive subtypes to demethylate and subsequently re-express specific, for example tumour suppressor genes such as APAF-1 (Fu et al, 2003; Cheng et al, 2004b). The gene discussed is APAF1; the disease is cancer.